Lyell Immunopharma
Overview
Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer. Lyell’s product candidates are enhanced with novel technology designed to …
Reach Lyell Immunopharma directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Lyell Immunopharma
Who are the partners at Lyell Immunopharma?
Team members listed for Lyell Immunopharma include Stephen Hill (Chief Operating Officer) and Jigar Desai (Vice President, Medical Affairs).
How do I contact Lyell Immunopharma?
Lyell Immunopharma's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database